Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2003 Mar;62(3):280–281. doi: 10.1136/ard.62.3.280

Anti-tumour necrosis factor α monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome

G Licata, A Pinto, A Tuttolomondo, A Banco, F Ciccia, A Ferrante, G Triolo
PMCID: PMC1754467  PMID: 12594127

Full Text

The Full Text of this article is available as a PDF (132.9 KB).

Figure 1.

Figure 1

Open in a new tab

Axial T2 weighed sequence MRI (0.5 T; TR (repetition time) 2500 ms; TE (echo time) 25 ms) at admission (A, B), after intravenous methylprednisolone and cyclophosphamide (C, D), and after anti-TNF therapy (E, F).

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES